Enedra Therapeutics Limited (13433538) is a private limited with share capital incorporated on 02/06/2021 (4 years old) and registered in cambridge, CB12LA. The company operates under SIC code 72190 and is classified as Micro.
Enedra therapeutics develops the first personalised medicines that treat heterogeneous cancers, a formidable challenge in oncology
Termination Director Company With Name Termination Date
Category:Officers
Date:24-12-2025
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:05-09-2025
Change Account Reference Date Company Previous Shortened
Category:Accounts
Date:04-09-2025
Appoint Person Director Company With Name Date
Category:Officers
Date:04-09-2025
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:04-07-2025
Confirmation Statement With Updates
Category:Confirmation Statement
Date:23-06-2025
Resolution
Category:Resolution
Date:20-12-2024
Termination Director Company With Name Termination Date
Category:Officers
Date:16-12-2024
Appoint Person Director Company With Name Date
Category:Officers
Date:16-12-2024
Capital Allotment Shares
Category:Capital
Date:25-11-2024
Appoint Person Director Company With Name Date
Category:Officers
Date:12-11-2024
Capital Allotment Shares
Category:Capital
Date:03-10-2024
Gazette Filings Brought Up To Date
Category:Gazette
Date:24-08-2024
Confirmation Statement With Updates
Category:Confirmation Statement
Date:21-08-2024
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:21-08-2024
Change Person Director Company With Change Date
Category:Officers
Date:21-08-2024
Gazette Notice Compulsory
Category:Gazette
Date:20-08-2024
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:19-08-2024
Change Person Director Company With Change Date
Category:Officers
Date:19-08-2024
Capital Allotment Shares
Category:Capital
Date:05-06-2024
Resolution
Category:Resolution
Date:05-06-2024
Resolution
Category:Resolution
Date:05-06-2024
Accounts Amended With Accounts Type Total Exemption Full
Category:Accounts
Date:08-02-2024
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:17-01-2024
Change Account Reference Date Company Previous Extended
Category:Accounts
Date:28-11-2023
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:07-07-2023
Change Person Director Company With Change Date
Category:Officers
Date:12-04-2023
Appoint Person Director Company With Name Date
Category:Officers
Date:12-04-2023
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:03-11-2022
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:24-08-2022
Gazette Filings Brought Up To Date
Category:Gazette
Date:24-08-2022
Gazette Notice Compulsory
Category:Gazette
Date:23-08-2022
Confirmation Statement With Updates
Category:Confirmation Statement
Date:19-08-2022
Memorandum Articles
Category:Incorporation
Date:16-05-2022
Capital Cancellation Shares
Category:Capital
Date:16-05-2022
Resolution
Category:Resolution
Date:16-05-2022
Capital Return Purchase Own Shares
Category:Capital
Date:16-05-2022
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:06-05-2022
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:06-05-2022
Termination Director Company With Name Termination Date
Category:Officers
Date:06-05-2022
Capital Allotment Shares
Category:Capital
Date:19-11-2021
Appoint Person Director Company With Name Date
Category:Officers
Date:22-10-2021
Appoint Person Director Company With Name Date
Category:Officers
Date:22-10-2021
Incorporation Company
Category:Incorporation
Date:02-06-2021
Innovate Grants
1
This company received a grant of £688170.0 for Discovery Of Novel Personalised Therapies For Genetically Heterogeneous, Immunotherapy Resistant Cancers.. The project started on 01/11/2024 and ended on 31/01/2026.